Exact Mass: 516.2934
Exact Mass Matches: 516.2934
Found 212 metabolites which its exact mass value is equals to given mass value 516.2934
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
L-Olivosyl-oleandolide
3-O-(alpha-L-olivosyl)oleandolide is a macrolide that is oleandolide having a 2,6-dideoxy-alpha-L-arabino-hexopyranosyl (alpha-L-olivosyl) residue attached at position 3. It has a role as a metabolite. It is a macrolide, a glycoside and a monosaccharide derivative. It is functionally related to an oleandolide. L-Olivosyl-oleandolide is a naturally occurring sesquiterpene lactone derivative that contains an olivosyl moiety, which is a specific type of ester derived from olivolic acid. The "L" in the name indicates that the olivosyl group is in the L-configuration, which refers to the spatial arrangement of atoms around the chiral center in the molecule. This compound is an example of a glycosylated sesquiterpene lactone, where the sesquiterpene lactone oleandolide is modified by the attachment of the olivosyl group. The presence of the olivosyl group can alter the biological properties of the parent compound, oleandolide, potentially affecting its pharmacological activities such as cytotoxicity, anti-inflammatory effects, and antimicrobial activity. L-Olivosyl-oleandolide can be found in certain plant species and may contribute to the plant's defense mechanisms against pathogens and herbivores. In its chemical structure, L-Olivosyl-oleandolide consists of a sesquiterpene lactone core with a lactone ring fused to a sesquiterpene framework, and it is appended with the L-olivosyl ester group, which adds complexity to its molecular structure and function. This compound is of interest in the fields of natural products chemistry and pharmacognosy for its potential therapeutic applications and as a subject of study for understanding the biosynthesis of such natural products.
6-O-Acetyl-2,3,4-tri-O-<(+)-3-methylvaleryl>-beta-D-glucose
(1beta,5beta,7alpha,8xi,9beta,10alpha,11alpha,14beta)-7,8,11,14-tetrahydroxypimar-15-en-1-yl beta-D-glucopyranoside|ent-isopimanervoside B
2,6-Diacetyl-3,4-diisobutyryl-1-O-octylglucopyranoside
2beta,15S,16,17,19-pentahydroxyisopimar-8(14)-ene 17-O-beta-D-glucopyranoside
Ile Gln Lys Glu
Lys Gln Ile Glu
Asp Lys Arg Val
Asp Lys Val Arg
Asp Arg Lys Val
Asp Arg Val Lys
Asp Val Lys Arg
Asp Val Arg Lys
Glu Ile Lys Gln
Glu Ile Gln Lys
Glu Lys Ile Gln
Glu Lys Leu Gln
Glu Lys Gln Ile
Glu Lys Gln Leu
Glu Leu Lys Gln
Glu Leu Gln Lys
Glu Gln Ile Lys
Glu Gln Lys Ile
Glu Gln Lys Leu
Glu Gln Leu Lys
Ile Glu Lys Gln
Ile Glu Gln Lys
Ile Lys Glu Gln
Ile Lys Gln Glu
Ile Gln Glu Lys
Ile Gln Arg Thr
Ile Gln Thr Arg
Ile Arg Gln Thr
Ile Arg Thr Gln
Ile Thr Gln Arg
Ile Thr Arg Gln
Lys Asp Arg Val
Lys Asp Val Arg
Lys Glu Ile Gln
Lys Glu Leu Gln
Lys Glu Gln Ile
Lys Glu Gln Leu
Lys Ile Glu Gln
Lys Ile Gln Glu
Lys Lys Asn Gln
Lys Lys Gln Asn
Lys Leu Glu Gln
Lys Leu Gln Glu
Lys Asn Lys Gln
Lys Asn Gln Lys
Lys Gln Glu Ile
Lys Gln Glu Leu
Lys Gln Lys Asn
Lys Gln Leu Glu
Lys Gln Asn Lys
Lys Arg Asp Val
Lys Arg Val Asp
Lys Val Asp Arg
Lys Val Arg Asp
Leu Glu Lys Gln
Leu Glu Gln Lys
Leu Lys Glu Gln
Leu Lys Gln Glu
Leu Gln Glu Lys
Leu Gln Lys Glu
Leu Gln Arg Thr
Leu Gln Thr Arg
Leu Arg Gln Thr
Leu Arg Thr Gln
Leu Thr Gln Arg
Leu Thr Arg Gln
Asn Lys Lys Gln
Asn Lys Gln Lys
Asn Gln Lys Lys
Gln Glu Ile Lys
Gln Glu Lys Ile
Gln Glu Lys Leu
Gln Glu Leu Lys
Gln Ile Glu Lys
Gln Ile Lys Glu
Gln Ile Arg Thr
Gln Ile Thr Arg
Gln Lys Glu Ile
Gln Lys Glu Leu
Gln Lys Ile Glu
Gln Lys Lys Asn
Gln Lys Leu Glu
Gln Lys Asn Lys
Gln Leu Glu Lys
Gln Leu Lys Glu
Gln Leu Arg Thr
Gln Leu Thr Arg
Gln Asn Lys Lys
Gln Arg Ile Thr
Gln Arg Leu Thr
Gln Arg Thr Ile
Gln Arg Thr Leu
Gln Thr Ile Arg
Gln Thr Leu Arg
Gln Thr Arg Ile
Gln Thr Arg Leu
Arg Asp Lys Val
Arg Asp Val Lys
Arg Ile Gln Thr
Arg Ile Thr Gln
Arg Lys Asp Val
Arg Lys Val Asp
Arg Leu Gln Thr
Arg Leu Thr Gln
Arg Gln Ile Thr
Arg Gln Leu Thr
Arg Gln Thr Ile
Arg Gln Thr Leu
Arg Thr Ile Gln
Arg Thr Leu Gln
Arg Thr Gln Ile
Arg Thr Gln Leu
Arg Val Asp Lys
Arg Val Lys Asp
Thr Ile Gln Arg
Thr Ile Arg Gln
Thr Leu Gln Arg
Thr Leu Arg Gln
Thr Gln Ile Arg
Thr Gln Leu Arg
Thr Gln Arg Ile
Thr Gln Arg Leu
Thr Arg Ile Gln
Thr Arg Leu Gln
Thr Arg Gln Ile
Thr Arg Gln Leu
Val Asp Lys Arg
Val Asp Arg Lys
Val Lys Asp Arg
Val Lys Arg Asp
Val Arg Asp Lys
Val Arg Lys Asp
9-[(E)-3-methyl-4-[(2S,3R,4S,5R)-3,4,5-trihydroxy-5-[[3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]but-2-enoyl]oxynonanoic acid
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(2-morpholin-4-ylacetyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(2-morpholin-4-ylacetyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(2-morpholin-4-ylacetyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-[2-(4-morpholinyl)-1-oxoethyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
2,3-dihydroxypropyl [2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propyl] hydrogen phosphate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
3-O-(alpha-L-olivosyl)oleandolide
A macrolide that is oleandolide having a 2,6-dideoxy-alpha-L-arabino-hexopyranosyl (alpha-L-olivosyl) residue attached at position 3.
(1r,9s,10s,12s,14e,16s,19r,20r,21s,22r)-3,9-dihydroxy-10,12,14,16,20,21,22-heptamethyl-8-(methylsulfanyl)-23,24-dioxatetracyclo[17.3.1.1⁶,⁹.0²,⁷]tetracosa-2,5,7,14-tetraen-4-one
(1s,3r,5s,7s,8r)-5-benzoyl-8-[(2r)-3,3-dimethyloxiran-2-yl]-6,6-dimethyl-1,3-bis(3-methylbut-2-en-1-yl)adamantane-2,4,9-trione
2-(hydroxymethyl)-6-{[1-(hydroxymethyl)-1,4a-dimethyl-7-(1,2,3-trihydroxypropan-2-yl)-2,3,4,4b,5,6,7,8,10,10a-decahydrophenanthren-2-yl]oxy}oxane-3,4,5-triol
3,9-dihydroxy-10,12,14,16,20,21,22-heptamethyl-8-(methylsulfanyl)-23,24-dioxatetracyclo[17.3.1.1⁶,⁹.0²,⁷]tetracosa-2,5,7,14-tetraen-4-one
(1r,3br,4r,5ar,9ar,9br,11as)-3b,6,6,9a,11a-pentamethyl-7-oxo-1-(5-oxo-2h-furan-3-yl)-1h,2h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl benzoate
({3,13,19-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-1(21),2,4,6,10,18(22),19-heptaen-9-yl}oxy)methanimidic acid
2,6-diacetyl-3,4-diisobutyryl-1-o-octylgluco-pyranoside
{"Ingredient_id": "HBIN004873","Ingredient_name": "2,6-diacetyl-3,4-diisobutyryl-1-o-octylgluco-pyranoside","Alias": "NA","Ingredient_formula": "C26H44O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5331","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β,21β,22β,24-tetrahydroxyolean-12-en-3-o-α-l-rhamnopyranosyl-(1→3)-[α-l-rhamnopyra-nosyl-(1→2)]-β-d-galactopyranosyl-(1→2)-β-d-glucuronopyranosyl-21-o-α-l-rhamnopyra-noside
{"Ingredient_id": "HBIN008057","Ingredient_name": "3\u03b2,21\u03b2,22\u03b2,24-tetrahydroxyolean-12-en-3-o-\u03b1-l-rhamnopyranosyl-(1\u21923)-[\u03b1-l-rhamnopyra-nosyl-(1\u21922)]-\u03b2-d-galactopyranosyl-(1\u21922)-\u03b2-d-glucuronopyranosyl-21-o-\u03b1-l-rhamnopyra-noside","Alias": "NA","Ingredient_formula": "C32H40N2O4","Ingredient_Smile": "CC(CC1=CC(=CC=C1)OCCC23CC4CC(C2)CC(C4)C3)NCC(C5=C6C=CC(=O)NC6=C(C=C5)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21131","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}